Related Experiment Videos

Inhibition of beta-propiolactone-induced mutagenesis and neoplasia by sodium thiosulfate

Cancer Research
|August 15, 1987
PubMed

Insights

Sodium thiosulfate (STS) effectively inhibits mutagenesis from stomach carcinogens. This nucleophile shows potential for chemoprevention by trapping harmful electrophiles in the stomach.

Area of Science:

  • Toxicology
  • Chemoprevention
  • Gastrointestinal Health

Background:

  • Direct-acting carcinogens pose a risk for stomach cancer.
  • Identifying compounds to neutralize these carcinogens in the stomach is crucial for prevention.

Purpose of the Study:

  • To investigate the potential of sodium thiosulfate (STS) as a chemopreventive agent against direct-acting carcinogens in the stomach.

Main Methods:

  • In vitro assessment of STS nucleophilicity at acidic pH.
  • In vivo experiments using A/J mice treated with STS prior to carcinogen exposure.
  • Evaluation of forestomach tumor formation.

Main Results:

  • STS maintained nucleophilicity in acidic conditions (pH 2).
  • STS significantly inhibited mutagenesis induced by beta-propiolactone and styrene oxide.
  • Administration of STS before beta-propiolactone reduced forestomach tumor incidence in mice.

Conclusions:

  • Sodium thiosulfate (STS) demonstrates efficacy in neutralizing direct-acting carcinogens.
  • STS's ability to function in acidic environments makes it a promising candidate for stomach chemoprevention.
  • Nucleophile-based strategies offer a potential approach for preventing carcinogen-induced cancers.

Related Concept Videos